Herpes simplex virus type 1 (HSV-1) is a neurotrophic gene and subsequent repair of the vector genome by human pathogen that naturally persists in neurons in a lathomologous recombination with a transgene expression ent state and carries a large number of viral functions plasmid. Potential recombinants indentified by a 'clear plawhich can be replaced by foreign genes to create a vector que' phenotype after X-gal staining arose at high frequency for gene therapy applications. In this report we describe a (80-100%). Of these, recombinants containing the transtwo-step method for insertion/deletion mutagenesis of HSV gene in place of the lacZ gene ranged from 19-65%. Insergenes and the efficient insertion of transgenes into these tion of the transgene expression construct into the viral locations in the viral genome. The first step is the insertion genome eliminates the PacI sites, allowing this method to of a reporter gene (lacZ) cassette flanked by PacI restricbe used repeatedly for the sequential deletion of multiple tion enzyme sites not otherwise found in the viral genome, HSV genes while inserting multiple transgenes. This prousing standard marker transfer procedures to interrupt a cedure was repeated in succession to produce a vector portion of the target HSV gene. The second step is substicarrying two independent expression cassettes at distinct tution of the reporter gene with other foreign cDNAs by viral loci. digestion of the vector DNA with PacI to remove the lacZ Keywords: Herpes simplex virus type 1; gene therapy vectors; homologous recombination Herpes simplex type 1 virus (HSV-1) gene vectors have DNA containing the desired mutation or transgene construct flanked by viral sequences, having homology with biological features that allow for gene transfer to nondividing cells. [1] [2] [3] Although HSV-1 naturally establishes the recombination target locus. The frequency of recombination obtained by this method is proportional to the latency in neurons, the virus can efficiently infect a wide range of human and animal cell types at low MOI. 4, 5 The size of the homologous flanking regions and ranges from less than 0.1 to 5% (D Krisky, unpublished observation). linear double-stranded DNA is approximately 152 kb in length and encodes more than 80 gene products, approxiThere are at least two reasons for the low frequency of recombinant mutants obtained. First, homologous recommately half of which are nonessential for virus production in culture but which contribute importantly to bination is inherently inefficient, and second a mutation that interrupts an HSV gene often reduces the efficiency the virus life cycle in the host. 6 Theoretically up to 40 kb of nonessential HSV-1 genomic DNA could be replaced of virus growth resulting in a greater proportion of virus yield represented by unmodified parental virus. by foreign sequences. 7 Viral genes essential for replication in cell culture can also be deleted provided that
In this report, we describe a two-step procedure designed for the efficient production of recombinant complementing cell lines are available for mutant virus propagation. 8, 9 HSV-1 viral genes are almost entirely virus vectors. In the first step, a specific viral locus is targeted for deletion by marker transfer of a reporter lacZ organized as contiguous unspliced units which facilitates their manipulation. We were interested in developing gene expression cassette flanked by restriction enzyme recognition sequences (PacI) not found in the wild-type methods to facilitate the insertion of transgenes into specific loci in the genome for the convenient production of viral genome. The insertion mutant produced plaques that turn blue following treatment with X-gal reagent. recombinant vectors carrying multiple transgenes at independent sites in the viral genome.
Digestion of viral DNA from these recombinant viruses results in release of the reporter construct and the generThe standard marker transfer method for producing HSV-1 mutants or recombinant viruses employs cotransation of two large viral DNA fragments which are unable to produce infectious virus upon transfection unless the fection of purified viral DNA with linearized plasmid viral genome is repaired. In the second step, cotransfection of digested viral DNA with a replacement transgene expression cassette inserted between the same viral plaques on X-gal staining. Virus containing the transgene sequence. In the second plasmid (pZ1) the HCMV IEp:lacZ:SV40pA construct was placed within the ICP47 expression construct is more easily purified using this method because the viral genome must be repaired for coding sequence. In the third plasmid (p41ICP0lacZ) the reporter gene construct was placed under transcriptional the production of infectious progeny virus, parental virus has no growth advantage over recombinants and there is control of the HSV ICP0 IE promoter and inserted in the HSV UL41 gene coding sequence. These plasmids were a blue plaque to clear plaque phenotypic change in the recombinants. Because insertion of the transgene confurther modified by the placement of additional unique restriction sites (ClaI, XbaI, EcoRI) flanking the lacZ struct into the virus removes the PacI sequences from the viral genome, this method may be used sequentially for reporter cassette. Five micrograms of S4TK genomic DNA was cotransfected with 1 g of linearized plasmid the deletion of multiple viral genes and the introduction of multiple different transgene expression constructs into DNA using the CaPO 4 method on to a monolayer of 7B cells in a 60-mm culture plate. Recombinant viruses crethe viral genome.
All experiments were carried out using the replicationated by the disruption of ICP22 (DHZ.1), U L 41 (SOZ.1), and ICP47 (DHZ.2) and their replacement by the lacZ defective mutant S4TK, a recombinant mutant virus derivative of d120, 8 a mutant HSV-1 (KOS) strain deleted expression cassettes were identified by their blue plaque phenotype after X-gal staining (shown in Figure 2a ). for both copies of the gene encoding the essential immediate-early (IE) transcriptional transactivator proRecombination with the ICP47 targeting plasmid resulted in disruption of U S 10 and 11 as well as ICP47 in DHZ.2. tein ICP4, and therefore incapable of replicating in noncomplementary cells that do not provide the essential Blue plaques were found with a frequency of 1/2000 with the deletion of ICP22, 1/333 with the deletion of UL41, ICP4 gene product in trans. S4TK differs from the d120 ICP4 null mutant due to replacement of the HSVtk (U L 23) and 1/33 with the deletion of ICP47. These frequencies correlate with the known effect of deletion of these genes endogenous promoter with the ICP4 IE promoter resulting in deletion of the U L 24 gene. The virus was on viral growth characteristics despite the fact that each of these viruses is also deleted for ICP4. 10,11 Virus recompropagated on 7B cells which provide the vectorinducible essential HSV IE gene products ICP4 and ICP27
binants from individual blue plaques were purified to homogeneity by three rounds of limiting dilution. The in trans. Three different targeting plasmids were constructed ( Figure 1 ). The reporter construct in all cases appropriate genotype including the targeted deletion, PacI sites, and reporter cassette were confirmed by Southconsisted of a lacZ gene having an SV40 polyadenylation signal flanked by PacI restriction sites. In the first plasmid ern blot analysis.
The lacZ reporter was then removed from the recombi-(pB5) the reporter gene, under the transcriptional control of the human cytomegalovirus (HCMV) IE promoter and nant viruses containing PacI sites (DHZ.1, DHZ.2 and SOZ.1) and replaced by a transgene. PacI digestion of having an additional bovine growth hormone polyadenylation signal, was placed within the ICP22 coding viral DNA from these mutants released the lacZ gene and resulted in the generation of two large viral genomic fragments. After phenol/chloroform extraction, ethanol precipitation and resuspension in distilled water the digested viral DNA was cotransfected with a transgene containing plasmid with the same viral flanking sequences as the original targeting plasmid (Figure 2b ). Recombinants containing the transgene in place of the lacZ reporter gene were identified from among clear plaque producing viruses by Southern blot analysis. The frequency of recombinants containing the transgene ranged from 19-66% of plaques examined ( Table 1) . Screening of 10 clear plaques by Southern blot invariably resulted in the identification of at least one recombinant containing the transgene. This method was highly reproducible with most recombinants being isolated after one transfection attempt. Clear plaque isolates negative for transgene insertion were found to contain a single PacI site suggesting in vivo ligation of the digested viral DNA. Southern blot analysis also demonstrated that insertion of the transgene construct into the viral genome resulted in elimination of the unique PacI sequences which originally flanked the lacZ reporter construct. Using this method we have now inserted over 20 different genes into five different loci in the genome (data not shown).
Figure 1 Targeting plasmids used for lacZ insertion/mutation of ICP22,
We repeated the same procedure to insert a second sequence ( Figure 3 ). After purification, the resulting viral Figure 4b , ii). A probe to the expected flanking sequences hybridized to a similar size band ( Figure 4a, probe a;  Figure 4b , ii). Probe c to the hIL-2 coding sequence hybridized to a BamHI fragment of approximately 5000 bp, which also hybridized with a probe to the expected flanking sequences (Figure 4a, probes a and c; Figure 4b , ii). The fragment containing the hIL-2 sequence was larger than the predicted size (4287 bp, 1387 viral sequences plus 2900 bp expression construct). Analysis with a smaller probe complementary to a sequence just 5′ to the ICP22 transgene insertion point revealed that both the hB7.1 and hIL-2 viral fragments contained the ICP22 5′ flanking sequence ( Figure 4a , probe e; Figure  4b , ii). This suggested that after insertion of the second expression construct (hB7.1) a recombination event occurred in the viral genome in which the sequence 5′ to the ICP22 insertion point (Figure 4b,*) was recombined into the ICP47 locus creating a second copy of this sequence bordering the hIL-2 expression construct. This explains the increased size of the BamHI fragment containing the hIL-2 expression construct (1976 bp viral sequences 5′ ICP22 and 2900 bp expression construct for an expected total of 4876 bp). This recombination event was most likely due to the presence of the HCMV promoter construct for both expression cassettes since incorporation of the second transgene construct resulted in the generation of identical sequences (f1, sequence of inverted repeat bordering the unique short region; and f2, HCMV promoter) which flank the remaining 5′ ICP22 and 5′ ICP47 sequences (Figure 4b , ii). This arrangement was confirmed by the finding that only one viral fragment contained the sequence 3′ to the ICP22 transgene insertion point ( Figure 4a , probe f; Figure 4b , ii) which matched the expected size of approximately 3044 bp. Similar blots were also probed with a sequence contained within the inverted repeat bordering the unique short region to verify the integrity of the unique short region. A number of other methods have been employed to improve efficiency for the production of HSV-1-based DNA (7G6) was digested with PacI to remove the lacZ reporter construct and a second transgene (hB7.1) was whole virus vectors. 12- 15 We and others have reported on the use of the P1 phage Cre-lox recombination system as inserted into the HSV genome by cotransfection of a modified pB5 plasmid which contained a hB7. 1 an alternative strategy for construction of high yield recombinant viruses. [15] [16] [17] Transgene and reporter gene expression construct within ICP22 flanking sequences (p6B7.1) (Figure 3) . Of virus recovered from this transfeccassettes cloned into lox P bearing plasmids can be enzymatically targeted for recombination into an existing lox tion, 100% demonstrated a clear plaque phenotype upon X-gal staining and three of 10 single clear plaque isolates P site previously engineered into a recipient viral genome using purified Cre recombinase in a cell-free reaction. The PacI method for the production of recombinant vectors has a number of advantages compared with the Subsequently, the reaction products can be introduced into susceptible host cells and plaques containing recomuse of enzymatic viral DNA manipulations when used for the production of HSV-1-based vectors. Each step of binant virus identified by reporter gene expression. The existing recombination locus and the effect of its mutated virus production, whether viral gene deletion or therapeutic transgene insertion, involves a plaque phenotype gene (eg defective tk) on viral growth is present in the parental virus thereby eliminating the growth advantage which can be screened by simple staining with X-gal reagent thereby reducing the time necessary for detection normally inherent in the parental virus over recombinants. Recombinant virus yield can vary; 10% recombiand purification of virus recombinants. Although transgene-containing viruses are easily isolated using this nants are routinely isolated, and can approach 50% using this method. 17 A drawback of this system is that the method, a significant proportion of clear plaques result from in vivo ligation of the digested viral DNA. Further entire lox-bearing bacterial plasmid along with the transgene sequences are introduced into the viral genome and studies have been undertaken to reduce the potential of in vivo ligation through the use of noncompatible unique due to the retention of the lox sites in the recombinants, the method can not readily be applied to multiple loci.
restriction enzyme sites to flank the lacZ gene in the targeting plasmid construct. The presence of unique ClaI, Another strategy for targeted deletion of genes within a specific viral locus involves a two-step process whereby EcoRI and XbaI restriction enzyme sites flanking the lacZ reporter construct in the original targeting plasmids a selectable marker is inserted into the genome then replaced by desired sequences. Post et al 12 described a allows convenient cloning of transgenes into these plasmids reducing the time required for production of method whereby a HSVtk expression cassette is inserted into the viral genome by homologous recombination into plasmids used for recombination into the viral genome. Sequential use of the PacI method offers the opporta viral background which is deleted for HSVtk in its native locus. Viruses which produce HSVtk can be isounity to delete multiple viral genes encoding additional immediate-early proteins or tegument proteins. Deletion lated from HSVtk-negative viruses through HAT selection on cells which do not produce cellular tk. In the of such genes from replication-defective HSV-1 vectors based on d120 (ICP4 − ) results in a reduction of virussecond step of this method, the HSVtk expression cassette is removed or replaced with other sequences by homolomediated cytotoxicity culminating in more efficient gene transfer due to a reduction in cell death following gous recombination. Viruses in which HSVtk is deleted from the genome can be isolated using Ara T selection; infection and subsequently improved transgene expression. 18, 19 Each viral gene deleted using this method treatment with this drug kills cells infected with HSVtkpositive virus allowing isolation of HSVtk-negative virus.
can be used for insertion of additional transgene expression constructs allowing this method to be used to The efficiency of this method is often reduced by the repair of HSVtk in its native locus in the first step of produce viral mutants which express multiple transgenes. The multiple transgene containing recombinant recombination and the development of spontaneous mutations in the HSVtk gene during the second step of viruses produced using this method are stable following propagation in culture suggesting that additional transrecombination, a problem seen with the use of any marker gene under selective pressure. In order to utilize genes could be inserted into the genome using this method. This method has not been used for insertion of this method for the manipulation of viruses deleted for essential viral genes complementing cell lines have to be transgenes into the repeat regions of the virus. If the expression cassette was recombined into a repeat region produced which are also rendered HSVtk-negative.
Other methods for generation of recombinant HSV-1 then upon digestion the viral genome would be cut into three pieces and most likely would need to be repaired viruses have also been reported which are based on the generation of a unique restriction enzyme site within the at two loci and could lead to a reduction in transfection efficiency. We have not yet attempted recombination HSV genome. Rixon and McLauchlan 13 described a system whereby XbaI sites were removed from the HSV geninvolving repair at multiple loci but these experiments are in progress. ome and an RsaI site in the unique short region was converted to a unique XbaI site. After XbaI digestion of viral Previous methods involving the use of unique restriction enzyme sites or sequences in the viral genome result DNA, exogenous DNA fragments with XbaI termini could be ligated into the genome. This method is limited in maintenance of these sequences following transgene recombination. The presence of these unique sequences to one viral locus and cannot be used sequentially for deletion of viral genes at multiple loci. Huang et al 14 in recombinants precludes subsequent repeated use. Since these other methods utilize unique sites normally described a similar system with the addition of a unique PacI site into the latency associated transcript (LAT) found in the genome they are further hampered by the inability to target other specific viral loci. In the method region of HFEM, an HSV-1 mutant which lacks 4.1 kb in one copy of the LAT locus of the inverted long repeat described in this report, the insertion of unique restriction enzyme sites during the viral manipulation used for region. The presence of a unique SwaI site in this region presents the opportunity for a PacI/SwaI double digesdeletion of viral genes allows this method to be used at any location within the viral genome thus increasing its tion of viral DNA resulting in a site for directional in vitro ligation of exogenous DNA sequences into the genome. utility in producing recombinant viruses. Since this method offers the ability to efficiently produce vectors This prevents the possibility of ligation of 'sticky ends' of viral DNA during the in vitro ligation process as well defective in multiple essential IE genes, the expression of multiple transgenes can be achieved in highly defective as in vivo ligation following transfection. When utilized in conjunction with a parental virus which contains a lacZ virus backgrounds which allow greatly improved duration of transgene expression and transduced cell surreporter gene within these loci, screening for recombinants is aided by blue plaque/clear plaque transitions.
vival. The ability to construct multigene virus recombi-
